Skip to main content

Advertisement

Log in

A multi-target approach for discovery of antiviral compounds against dengue virus from green tea

  • Original Article
  • Published:
Network Modeling Analysis in Health Informatics and Bioinformatics Aims and scope Submit manuscript

A Correction to this article was published on 23 July 2020

This article has been updated

Abstract

Dengue virus (DENV) infection is one of the largest threats worldwide, and there is no any specific drug available in the market to combat its serious causes. In the present study, we attempted to screen the potential of green tea to inhibit DENV infection through known DENV multi-target, viz. nonstructural protein 1 (NS1), RNA dependent RNA polymerase domain (RDRP), and methyltransferase domain of non-structural protein 5 (MTD). A total of 25 bioactive compounds from the green tea were docked against the selected targets that result into only three compounds with substantial binding affinity above − 9 kcal/mol. Evaluation of these docked complexes through molecular dynamics simulations suggested the considerable stability of Compound-1 and Compound-2 with selected DENV targets whilst no significant stability was recorded for the Compound-3. Hence, Compound-1 and Compound-2 were concluded with potential inhibitory activity against DENV NS1, RDRP, and MTD; and suggested to validate their anti-dengue activity through in vitro and in vivo experiments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Change history

  • 23 July 2020

    In results and discussion section, the description of figures was revised as follows. In the case of NS1-Compound-1 complex, consider an additional contact of Glu12 (Fig. 1a), in case of NS1-Compound-2 complex, six instead of four residues were involved in contact (Fig. 1b). In case of RDRP-Compound-1 complex, seven instead of three hydrogen bonds were formed (Fig. 1d), while in case of RDRP Compound-2 complex nine instead of seven hydrogen bonds were recorded (Fig. 1e). In case of MTD-complex 1 consider an addition contact of Leu17 (Fig. 1g).

References

  • Akey DL, Brown WC, Dutta S, Konwerski J, Jose J, Jurkiw TJ, DelProposto J, Ogata CM, Skiniotis G, Kuhn RJ, Smith JL (2014) Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science 343:881–885

    Article  Google Scholar 

  • Allonso D, Andrade IS, Conde JN, Coelho DR, Rocha DC, da Silva ML, Ventura GT, Silva EM, Mohana-Borges R (2015) Dengue virus NS1 protein modulates cellular energy metabolism by increasing glyceraldehyde-3-phosphate dehydrogenase activity. J Virol 89:11871–11883

    Article  Google Scholar 

  • Anciotti RS, Gubler DJ, Trent DW (1997) Molecular evolution and phylogeny of dengue-4 viruses. J Gen Virol 78:2279–2286

    Article  Google Scholar 

  • Anderson CR, Downs WG, Hill AE (1956) Isolation of dengue virus from a human being in Trinidad. Science 124:224–225

    Article  Google Scholar 

  • Bartholomeusz AI, Wright PJ (1993) Synthesis of dengue virus RNA in vitro: initiation and the involvement of proteins NS3 and NS5. Arch Virol 128:111–121

    Article  Google Scholar 

  • Benarroch D, Egloff MP, Mulard L, Guerreiro C, Romette JL, Canard B (2004) A structural basis for the inhibition of the NS5 dengue virus mRNA 2′-O-methyltransferase domain by ribavirin 5′-triphosphate. J Biol Chem 279:35638–35643

    Article  Google Scholar 

  • Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28:235–242

    Article  Google Scholar 

  • Bowers KJ, Chow E, Xu H, Dror RO, Eastwood MP, Brent A et al (2006) Scalable algorithms for molecular dynamics simulations on commodity clusters. In: Proceedings of the ACM/IEEE conference on supercomputing (SC06), Tampa, Florida, 2006, November 11–17

  • DeLano WL (2002) The PyMOL molecular graphics system. http://pymol.org

  • Dwivedi VD, Tripathi IP, Mishra SK (2016) In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease. J Vect Borne Dis 53:156–161

    Google Scholar 

  • Dwivedi VD, Tripathi IP, Tripathi RC, Bharadwaj S, Mishra SK (2017) Genomics, proteomics and evolution of dengue virus. Brief Funct Genom 16:217–227

    Google Scholar 

  • Gubler DJ (1998) Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11:480–496

    Article  Google Scholar 

  • Guzman MG, Alvarez M, Halstead SB (2013) Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. ArchVirol 158:1445–1459

    Google Scholar 

  • Hanley KA, Weaver SC (eds) (2010) Frontiers in dengue virus research. Caister Academic Press, Hethersett

    Google Scholar 

  • Ismail NA, Jusoh SA (2017) Molecular docking and molecular dynamics simulation studies to predict flavonoid binding on the surface of DENV2 E protein. Interdiscip Sci Comput Life Sci 9:499–511

    Article  Google Scholar 

  • Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, Han L, He J, He S, Shoemaker BA, Wang J (2015) PubChem substance and compound databases. Nucleic Acids Res 44:1202–1213

    Article  Google Scholar 

  • Labbé CM, Rey J, Lagorce D, Vavruša M, Becot J, Sperandio O, Villoutreix BO, Tufféry P, Miteva MA (2015) MTiOpenScreen: a web server for structure-based virtual screening. Nucleic Acids Res 43:448–454

    Article  Google Scholar 

  • Laskowski RA, Mark BS (2011) LigPlot + : multiple ligand–protein interaction diagrams for drug discovery. J Chem Inf Model 51:2778–2786

    Article  Google Scholar 

  • Lim SP, Noble CG, Shi PY (2015) The dengue virus NS5 protein as a target for drug discovery. Antiviral Res 119:57–67

    Article  Google Scholar 

  • MAESTRO, SCHRÖDINGER, LLC: Schrödinger release 2018-3

  • Low JG, Sung C, Wijaya L, Wei Y, Rathore AP, Watanabe S, Tan BH, Toh L, Chua LT, Chow A, Howe S (2014) Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet Infect Dis 14:706–715

    Article  Google Scholar 

  • Malet H, Masse N, Selisko B, Romette JL, Alvarez K et al (2008) The flavivirus polymerase as a target for drug discovery. Antiviral Res 80:23–35

    Article  Google Scholar 

  • Meng F, Badierah RA, Almehdar HA et al (2015) Unstructural biology of the dengue virus proteins. FEBS J282:3368–3394

    Article  Google Scholar 

  • Mustafa MS, Rasotgi V, Jain S et al (2015) Discovery of fifth serotype of dengue virus (DENV-5): a new public health dilemma in dengue control. Med JArmed Forces India 71:67–70

    Article  Google Scholar 

  • Noble CG, Lim SP, Arora R, Yokokawa F, Nilar S, Seh CC, Wright SK, Benson TE, Smith PW, Shi PY (2016) A conserved pocket in the dengue virus polymerase identified through fragment-based screening. J Biol Chem 291:8541–8548

    Article  Google Scholar 

  • Normile D (2013) Surprising new dengue virus throws a spanner in disease control efforts. Science 342:415

    Article  Google Scholar 

  • Perera R, Kuhn RJ (2008) Structural proteomics of dengue virus. Curr Opin Microbiol 11:369–377

    Article  Google Scholar 

  • Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF Chimera—a visualization system for exploratory research and analysis. J Comp Chem 25:1605–1612

    Article  Google Scholar 

  • Rodenhuis-Zybert IA, Wilschut J, Smit JM (2010) Dengue virus life cycle: viral and host factors modulating infectivity. Cell Mol Life Sci 67:2773–2786

    Article  Google Scholar 

  • Russell PK, Buescher EL, McCown JM et al (1966) Recovery of dengue viruses from patients during epidemics in Puerto Rico and East Pakistan. Am J Trop MedHyg 15:573–579

    Article  Google Scholar 

  • Sabin AB, Schlesinger RW (1945) Production of immunity to dengue with virus modified by propagation in mice. Science 101:640–642

    Article  Google Scholar 

  • Sarkar JK, Chatterjee SN, Chakravarty SK (1964) Haemorrhagic fever in calcutta: some epidemiological observations. Indian J Med Res 52:651–659

    Google Scholar 

  • Schmidtke P, Le Guilloux V, Maupetit J, Tuffery P (2010) Fpocket: online tools for protein ensemble pocket detection and tracking. Nucleic Acids Res 38:582–589

    Article  Google Scholar 

  • Schrödinger Release 2018–3: Desmond Molecular Dynamics System, D. E. Shaw Research, New York, NY (2018) Maestro-Desmond Interoperability Tools. Schrödinger, New York, p 2018

    Google Scholar 

  • Selisko B, Wang C, Harris E, Canard B (2014) Regulation of Flavivirus RNA synthesis and replication. Curr Opin Virol 9:74–83

    Article  Google Scholar 

  • Simmons CP, Farrar JJ, Van VCN et al (2012) Dengue. New Eng J Med 366:1423–1432

    Article  Google Scholar 

  • Tam DT, Ngoc TV, Tien NT, Kieu NT, Thuy TT, Thanh LT, Tam CT, Truong NT, Dung NT, Qui PT, Hien TT (2012) Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial. Clin Infect Dis 55:1216–1224

    Article  Google Scholar 

  • Tricou V, Minh NN, Van TP, Lee SJ, Farrar J, Wills B, Tran HT, Simmons CP (2010) A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults. PLoS Neglec Trop Dis 4:e785

    Article  Google Scholar 

  • Vázquez-Calvo Á, Jiménez de Oya N, Martín-Acebes MA, Garcia-Moruno E, Saiz JC (2017) Antiviral properties of the natural polyphenols delphinidin and epigallocatechin gallate against the flaviviruses West Nile virus, Zika virus, and dengue virus. Front Microbiol 8:1314

    Article  Google Scholar 

  • Whitehorn J, Nguyen CV, Khanh LP, Kien DT, Quyen NT, Tran NT, Hang NT, Truong NT, Hue Tai LT, Cam Huong NT, Nhon VT (2016) Lovastatin for the treatment of adult patients with dengue: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 62:468–476

    Google Scholar 

  • Xu J, Xu Z, Zheng W (2017) A review of the antiviral role of green tea catechins. Molecules 22:1–18

    MathSciNet  Google Scholar 

Download references

Acknowledgements

All the authors of this manuscript acknowledge Center for Bioinformatics, Computational and Systems Biology, Pathfinder Research and Training Foundation, Greater Noida, India for providing laboratory facilities.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Aditya Arya or Vivek Dhar Dwivedi.

Ethics declarations

Conflict of interest

Authors declare that there is no competing interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 6046 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mahajan, P., Tomar, S., Kumar, A. et al. A multi-target approach for discovery of antiviral compounds against dengue virus from green tea. Netw Model Anal Health Inform Bioinforma 9, 20 (2020). https://doi.org/10.1007/s13721-020-0222-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13721-020-0222-4

Keywords

Navigation